Why Some Treatments Don’t Work: Understanding GLP-1 Resistance Through Genetics

-




Why Some Treatments Don’t Work: Understanding GLP-1 Resistance Through Genetics

Introduction

In modern healthcare, treatments are often designed based on clinical trials and population-level outcomes. However, one important reality is becoming increasingly clear: not all treatments work equally for everyone.

A recent focus in medical research is on GLP-1 therapies, widely used for managing diabetes and supporting weight loss. While these treatments have shown remarkable results for many individuals, a significant group of patients does not respond as expected.

What is GLP-1 and Why is it Important?

GLP-1 (Glucagon-Like Peptide-1) is a natural hormone in the body that plays a crucial role in:

  • Regulating blood sugar levels
  • Reducing appetite
  • Supporting weight management

Medications based on GLP-1 mechanisms have gained global attention due to their effectiveness in treating type 2 diabetes and obesity.

The Problem: Not Everyone Responds the Same Way

Despite the success of GLP-1-based treatments, studies show that a subset of individuals does not experience the expected benefits. In some cases:

  • Weight loss is minimal
  • Blood sugar control remains suboptimal

This raises an important question: Is the treatment ineffective, or is the body responding differently?

Understanding GLP-1 Resistance

GLP-1 resistance refers to a condition where:

  • The hormone is present in the body
  • But the body does not respond effectively to it

This is similar to other forms of resistance, such as insulin resistance. Even if the biological signal exists, the body’s response mechanism is impaired.

The Role of Genetics

Recent research indicates that genetic variations may influence how individuals respond to GLP-1 therapies. Approximately 1 in 10 individuals may carry genetic differences that affect:

  • Hormone signaling pathways
  • Receptor sensitivity
  • Metabolic response

This means two people can take the same medication but experience completely different outcomes.

Data Science Perspective: Why This Matters

From a data science and healthcare analytics perspective, this is highly significant. Traditional models of treatment rely on population averages and standard protocols. However, with genetic variability, these models may not be sufficient.

Key Implications for Data Science

  1. Need for Personalized Models: Predictive models must consider individual-level data.
  2. Integration of Multi-Omics Data: Combining genomics, clinical data, and lifestyle data can improve prediction accuracy.
  3. Predictive Analytics in Treatment Response: Machine learning can help identify who will respond to treatment and who may require alternatives.
  4. Early Risk Identification: Identifying resistance patterns early can reduce trial-and-error treatments and improve patient outcomes.

The Future: Personalized Medicine

Healthcare is gradually shifting towards personalized (precision) medicine. This approach focuses on tailoring treatments based on genetic profile, improving effectiveness, and reducing unnecessary interventions.

In the future, before prescribing a treatment, doctors may analyze genetic data, predict response, and customize therapy accordingly.

Bridging Traditional and Modern Insights

Interestingly, traditional systems like Siddha and Ayurveda have long emphasized that each individual is unique and treatment should be personalized. While modern science explains this through genetics, ancient systems described it through body constitution.

This convergence highlights an important truth: Individual variation has always been central to effective healthcare.

Conclusion

GLP-1 resistance is a powerful example of how genetics can influence treatment outcomes. It challenges the traditional approach of standardized treatments and pushes healthcare toward a more personalized future.

For professionals in healthcare, medical coding, and data science, this shift presents an opportunity to explore advanced analytics, work with complex datasets, and contribute to improved patient care.

Final Thought

“The future of healthcare is not just about treating diseases—it’s about understanding individuals.”



“Special thanks to Dr. Wei‑Wu He, based on whose post I chose the topic for my first blog article.”

Comments

Post a Comment

Popular posts from this blog

E/M Coding MDM Clarification: Lab Ordered and Reviewed — One Point or Two?

-
Image
E/M Coding MDM Clarification: Lab Ordered and Reviewed — One Point or Two? Medical coders often struggle with the Medical Decision Making (MDM) data table in E/M coding. One of the most debated points is: If a lab test is both ordered and reviewed, does it count as one point or two? MDM scoring determines the level of service — and over‑counting can lead to upcoding risks , while under‑counting can reduce legitimate reimbursement. Let's see how to calculate this and the supporting guidelines. The AMA CPT E/M Guidelines AMA Guideline states: “Tests are counted once per unique test, even if ordered and reviewed. Ordering and reviewing the same test is not counted separately.” CBC ordered and reviewed → 1 point CBC ordered + X‑ray ordered and reviewed → 2 points (one for each unique test) CBC ordered + external lab report reviewed (from another provider) → 2 points (because external data review is a separate element) Why Double‑Counting Is Risky Considering ...
Read more

Pregnancy Coding in Ancillary Charts: The Z3A.00 Confusion

-
Image
Pregnancy Coding in Ancillary Charts: The Z3A.00 Confusion Introduction Medical coders working in ancillary specialties often face unique challenges due to limited documentation. In many cases, coders only have access to the physician’s order and order plan. This becomes particularly complex when coding pregnancy charts, where gestational weeks are often missing. One common question arises: Can we assign Z3A.00 (weeks of gestation not specified) when no weeks are documented? General Guideline on Z3A Codes According to ICD-10-CM Official Guidelines: Z3A.xx codes (weeks of gestation) must be supported by documentation of the exact week. Z3A.00 is used only when the provider explicitly documents “unknown gestational age.” If weeks are not documented at all, no Z3A code should be assigned . In short, absence of documentation does not equal “unknown gestational age.” It simply means the coder should not assign Z3A. Why Clients Ask for Z3A.00 De...
Read more

Predicting Human Lifespan Using Healthcare Data Analytics: Can Ayurveda Add a New Dimension?

-
Image
Predicting Human Lifespan Using Healthcare Data Analytics: Can Ayurveda Add a New Dimension? Introduction Predicting human lifespan has always been a challenging yet fascinating goal in healthcare. With the rise of data science, predictive models are now used to estimate survival probabilities based on clinical and demographic data. However, most existing models rely purely on biomedical factors and often overlook deeper individualized and environmental influences. This article explores a unique and innovative idea: integrating Ayurvedic principles such as dosha (body constitution) and desha (geographical influence) into modern predictive analytics to improve lifespan prediction. Current Approach in Healthcare Data Analytics Modern prediction of survival is primarily done using techniques from Survival Analysis. These models do not predict exact lifespan but estimate probabilities such as: Risk of mortality within a specific time (e.g., 1 year, 5 years) Su...
Read more